These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12802033)

  • 41. The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview.
    Rex JH; Wingard JR; Wenzel R; Herbrecht R; Sobel J; Edwards JE
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S165-9. PubMed ID: 15546112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carriers of X-linked chronic granulomatous disease at risk.
    Roesler J
    Clin Immunol; 2009 Feb; 130(2):233; author reply 234. PubMed ID: 19004669
    [No Abstract]   [Full Text] [Related]  

  • 44. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH; Dixon CA; Goldberger MJ
    N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
    [No Abstract]   [Full Text] [Related]  

  • 45. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
    Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
    Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous itraconazole treatment for onychomycosis and dermatomycosis: an overview of safety.
    Nolting SK; Gupta A; Doncker PD; Jacko ML; Moskovitz BL
    Eur J Dermatol; 1999; 9(7):540-3. PubMed ID: 10523732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

  • 48. Tinea capitis.
    Seebacher C; Abeck D; Brasch J; Cornely O; Daeschlein G; Effendy I; Ginter-Hanselmayer G; Haake N; Hamm G; Hipler UC; Hof H; Korting HC; Kramer A; Mayser P; Ruhnke M; Schlacke KH; Tietz HJ
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1085-91. PubMed ID: 17176418
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
    Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
    Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rare diagnosis in a neonate who presents with fever.
    Davoodi P; Wright SA; Brown EV; Perry JR
    Clin Pediatr (Phila); 2015 Jan; 54(1):91-3. PubMed ID: 25022948
    [No Abstract]   [Full Text] [Related]  

  • 53. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis.
    Andes D; Proctor R; Bush RK; Pasic TR
    Clin Infect Dis; 2000 Jul; 31(1):202-4. PubMed ID: 10913428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Purposefulness of using fuzzy logic approaches in the rare disease clinical trials].
    Kiseleva TS; Pagava KI; Korinteli IA; Korinteli MG; Shonvadze DN
    Georgian Med News; 2011 Apr; (193):22-4. PubMed ID: 21617269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Images in clinical medicine. Chronic granulomatous disease.
    Esfandbod M; Kabootari M
    N Engl J Med; 2012 Aug; 367(8):753. PubMed ID: 22913685
    [No Abstract]   [Full Text] [Related]  

  • 57. Malar Rash in a Child with Chronic Granulomatous Disease.
    Vignesh P; Gupta A; Dogra S
    J Allergy Clin Immunol Pract; 2017; 5(2):473-474. PubMed ID: 28017630
    [No Abstract]   [Full Text] [Related]  

  • 58. The delayed-start study design.
    D'Agostino RB
    N Engl J Med; 2009 Sep; 361(13):1304-6. PubMed ID: 19776413
    [No Abstract]   [Full Text] [Related]  

  • 59. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 60. Methodology of clinical trials for rare diseases.
    Tudur Smith C; Williamson PR; Beresford MW
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.